Artelo Biosciences Current Cash

Artelo Biosciences (ARTL) currently reports a current cash of $10M as of March 2026. That compares with $750K in the prior-year period — up 1277.1% year over year. Use the charts on this page to explore Artelo Biosciences's current cash history and peer comparisons.

Artelo Biosciences's current cash increased from $750K to $10M — a 1277.1% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Artelo Biosciences reported $10M in current cash as of March 2026. That compares with $750K in the prior-year period — up 1277.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $10M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Artelo Biosciences, and consider following ARTL for alerts when major investors trade the stock.

Artelo Biosciences is classified in the Consumer Staples sector. On current cash, it currently shows $10M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Consumer Staples are usually more informative than comparing ARTL with unrelated industries.